Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Citigroup Maintains Buy on CrowdStrike Holdings, Lowers Price Target to $235

Citigroup analyst Fatima Boolani maintains CrowdStrike Holdings (NASDAQ:CRWD) with a Buy and lowers the price target from $245 to $235.
byBenzinga Newsdesk
July 22, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Citigroup analyst Fatima Boolani maintains CrowdStrike Holdings (NASDAQ:CRWD) with a Buy and lowers the price target from $245 to $235.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Scribe Therapeutics Expands Collaboration With Sanofi To Advance In Vivo Genetic Medicines For Sickle Cell And Other Genomic Diseases; Scribe To Receive $40M Upfront, With The Potential For More Than $1.2B In Milestones Across All Programs

By Happy Mohamed
July 17, 11:53 AM
Predicated on the progress of the companies' first collaboration, Sanofi has selected Scribe's novel CRISPR by Design™ approach to drive forward a new wave of in vivo genetic medicines Sanofi and Scribe

SNY

Read More

Why AppLovin Stock Is Up After Earnings

By Erica Kollmann
February 15, 3:25 PM
Wedbush analyst Nick McKay maintained AppLovin with an Outperform and raised the price target from $58.50 to $67 following the earnings report. AppLovin shares are climbing on heavy trading volume as investors digest the results. According to data from Benzinga Pro, more than 12.4 million shares have been traded in the session compared to the stock's 100-day volume of 3.012 million.

APP